Simon TA, Suissa S, Skovron ML, Frisell T, Askling J, Michaud K, Pedro S, Strangfeld A, Meissner Y, Boers M, Hoffman V, Dominique A, Gomez A, Hochberg MC. Infection outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: results from a 10-year international post-marketing study. Semin Arthritis Rheum. 2024 Feb;64:152313. doi: 10.1016/j.semarthrit.2023.152313
Wadud Z, Chintakayala P. Personal carbon trading: trade-off and complementarity between in-home and transport related emissions reduction. Ecol Econ. 2019 Feb;156:397-408. doi: 10.1016/j.ecolecon.2018.10.016
Martin SA, Coon CD, McLeod LD, Chandran A, Arnold LM. Evaluation of the fibromyalgia diagnostic screen in clinical practice. J Eval Clin Pract. 2014 Apr;20(2):158-65. doi: 10.1111/jep.12102
Van Houtven G, Mansfield C, Phaneuf DJ, von Haefen R, Milstead B, Kenney MA, Reckhow KH. Combining expert elicitation and stated-preference methods to value ecosystem services from improved lake water quality. Ecol Econ. 2014 Mar;99:40-52. doi: 10.1016/j.ecolecon.2013.12.018.
Thyagarajan (Hoffman) V, Norman H, Alexander KA, Napalkov P, Enger C. Risk of mortality, fatal infection, and fatal malignancy related to use of anti-tumor necrosis factor-α biologics by rheumatoid arthritis patients. Semin Arthritis Rheum. 2012 Dec;42(3):223-33. doi: 10.1016/j.semarthrit.2012.05.004
Brown TM, Garg S, Chandran AB, McNett M, Silverman SL, Hadker N. The impact of 'best-practice' patient care in fibromyalgia on practice economics. J Eval Clin Pract. 2012 Aug 1;18(4):793-8.
Bristow AL, Wardman M, Zanni AM, Chintakayala PK. Public acceptability of personal carbon trading and carbon tax. Ecol Econ. 2010 Jul 15;69(9):1824-37. doi: 10.1016/j.ecolecon.2010.04.021
Brogan AJ, Stidham S. A note on separation in mean-lower-partial-moment portfolio optimization with fixed and moving targets. IIE Trans. 2005 Jan 1;37(10):901-6.